The Efficacy of Kanamycin Plus Metronidazole Administration as an OABP Against Incisional Surgical Site Infection in Colorectal Cancer Surgery

  • Ichimanda Michihiro
    Department of Gastroenterological and Pediatric Surgery, Oita University Faculty of Medicine
  • Etoh Tsuyoshi
    Department of Gastroenterological and Pediatric Surgery, Oita University Faculty of Medicine
  • Nakajima Kentaro
    Department of Gastroenterological and Pediatric Surgery, Oita University Faculty of Medicine
  • Hiratsuka Takahiro
    Department of Gastroenterological and Pediatric Surgery, Oita University Faculty of Medicine
  • Akagi Tomonori
    Department of Gastroenterological and Pediatric Surgery, Oita University Faculty of Medicine
  • Shibata Tomotaka
    Center for Community Medicine, Oita University Faculty of Medicine
  • Ueda Yoshitake
    Department of Gastroenterological and Pediatric Surgery, Oita University Faculty of Medicine
  • Shiroshita Hidefumi
    Department of Gastroenterological and Pediatric Surgery, Oita University Faculty of Medicine
  • Inomata Masafumi
    Department of Gastroenterological and Pediatric Surgery, Oita University Faculty of Medicine

Bibliographic Information

Other Title
  • 大腸癌手術の化学的腸管処置におけるカナマイシンおよびメトロニダゾール併用投与の有用性

Search this article

Description

Aim: The purpose of this study was to assess the efficacy of kanamycin (KM) plus metronidazole (MNZ) administration as an oral antibiotic bowel preparation (OABP) for incisional surgical site infection (SSI) in colorectal cancer surgery.<BR>Methods: Three hundred forty-four patients who underwent elective colorectal surgery at our department from April 2010 to March 2015 were enrolled in this retrospective study. The patients were divided into three groups based on their OABP method: without OABP (n = 178), KM only (n = 87), and KM + MNZ (n = 79). We evaluated the incidence of adverse events and analyzed an association between the incidence of incisional SSI and variable factors using univariate and multivariate analyses. Results: Incisional SSI rates in each group were 14.0% (without OABP), 13.8% (KM only), and 1.3% (KM + MNZ). The KM + MNZ group had a significant lower SSI incidence than the other groups (P < 0.05). There was no significant difference in the incidence of adverse events among the groups. Risk factors for SSI were “male” (P = 0.035) and “without KM + MNZ” (P = 0.011).<BR>Conclusions: Administration of KM + MNZ as OABP was effective in preventing incisional SSI in colorectal cancer surgery.

Journal

Citations (1)*help

See more

References(15)*help

See more

Details 詳細情報について

Report a problem

Back to top